Browse the full record of transactions filed by 김지환, Dirigeant. Director active across 2 companies, notably 케이엠제약. Cumulatively, 9 disclosures have been logged. The latest transaction was filed on 21 April 2026 — Purchase. Regulator: DART (FSS). The full history is free.
Kim Ji-hwan is an executive at KM Pharmaceutical, a company active in the pharmaceutical sector. He contributes to the strategic management of the company and process optimization. His role is essential in ensuring KM Pharmaceutical's competitiveness in the market.